Mogal Harveshp D, Fino Nora, Clark Clancy, Shen Perry
Department of General Surgery, Section of Surgical Oncology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.
Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina.
J Surg Oncol. 2016 Aug;114(2):157-62. doi: 10.1002/jso.24276. Epub 2016 May 4.
Postoperative outcomes predicted by the ACS NSQIP universal risk calculator have not been validated for specific procedures like pancreaticoduodenectomy (PD).
A random sample of 400 PD patients from the NSQIP database was analyzed. Patients were categorized into four groups of 100 each based on ICD-9 diagnosis (211.6, 157.0, 156.2, and 577.1). Estimated risks of postoperative outcomes recorded by the calculator were compared to observed outcomes using the Brier Score (BS). The calculated BS was compared to a null model BS. A BS of zero indicated perfect prediction, while a BS of one indicated the poorest prediction.
BS for all groupings was generally low, reflecting good prediction. BS for any and major complications was higher (0.23 and 0.22, respectively). This was also seen within ICD-9 subgroups. For patients with ampullary cancer, BS for these outcomes was higher (0.27 and 0.26, respectively). Comparison to the null model BS (0.24 and 0.24, respectively) correlated lesser predictive accuracy of the calculator for this subgroup.
The ACS NSQIP risk calculator, although accurate in predicting outcomes in patients undergoing PD, shows variation when accounting for specific ICD-9 diagnoses. Incorporating the diagnosis may better guide surgeons and patients preoperatively in making informed decisions. J. Surg. Oncol. 2016;114:157-162. © 2016 Wiley Periodicals, Inc.
美国外科医师学会国家外科质量改进计划(ACS NSQIP)通用风险计算器预测的术后结果尚未在胰十二指肠切除术(PD)等特定手术中得到验证。
对NSQIP数据库中400例PD患者的随机样本进行分析。根据国际疾病分类第九版(ICD - 9)诊断(211.6、157.0、156.2和577.1)将患者分为四组,每组100例。使用Brier评分(BS)将计算器记录的术后结果估计风险与观察到的结果进行比较。将计算出的BS与零模型BS进行比较。BS为零表示预测完美,而BS为1表示预测最差。
所有分组的BS总体较低,反映出良好的预测效果。任何并发症和主要并发症的BS较高(分别为0.23和0.22)。在ICD - 9亚组中也观察到这种情况。对于壶腹癌患者,这些结果的BS较高(分别为0.27和0.26)。与零模型BS(分别为0.24和0.24)相比,该亚组计算器的预测准确性较低。
ACS NSQIP风险计算器虽然在预测PD患者的结果方面准确,但在考虑特定的ICD - 9诊断时存在差异。纳入诊断可能会在术前更好地指导外科医生和患者做出明智的决策。《外科肿瘤学杂志》2016年;114:157 - 162。©2016威利期刊公司